Warning signs of rheumatoid arthritis: symptoms, diagnosis, treatment and care costs

Key facts

• Rheumatoid arthritis commonly causes swollen, warm joints and morning stiffness lasting more than 60 minutes.
• Diagnosis combines symptoms, examination, blood tests and imaging because no single test establishes rheumatoid arthritis.
• United States biologic treatment estimates commonly range from $2,100 to $9,000 per month before coverage adjustments.
• Hospital-based infusion treatment may cost approximately $2,500 to $6,000 per treatment in published 2026 estimates.

Warning signs of rheumatoid arthritis usually involve an inflammatory pattern rather than one isolated ache. Persistent stiffness, swelling, warmth and reduced movement can warrant assessment, but these findings are not diagnostic by themselves. Rheumatoid arthritis is a chronic autoimmune disease that primarily affects joints and may also involve the lungs, eyes, skin or blood vessels. A qualified healthcare professional should evaluate suspected inflammatory arthritis, particularly when symptoms persist or interfere with normal activities.

Common warning signs and symptom patterns

Early rheumatoid arthritis may develop gradually, with minor joint pain, stiffness and fatigue. The small joints of the hands, wrists and feet are frequently involved, although knees, ankles, elbows, shoulders and hips may also be affected. Morning stiffness lasting more than one hour, or stiffness after inactivity, is a notable inflammatory pattern. Joints may feel warm, tender or swollen, and movement can become more limited over time. 1

Rheumatoid arthritis often affects corresponding joints on both sides of the body, although symmetry is not required. General symptoms can include weakness, fever or reduced energy. Less common manifestations may include dry eyes and mouth, eye irritation, numbness or tingling, skin nodules, and chest pain associated with breathing. Chest pain, significant breathing difficulty, a severely red or painful eye, or sudden neurological symptoms require urgent medical assessment rather than routine rheumatology scheduling. 2 1

How rheumatoid arthritis differs from other causes

Osteoarthritis is commonly associated with age-related wear in joints and often produces pain related to use, whereas rheumatoid arthritis is an immune-mediated inflammatory condition. A recent injury may explain symptoms concentrated around one damaged area, while infection can cause rapidly worsening redness, warmth, fever or severe pain. Gout, psoriatic arthritis, reactive arthritis and connective-tissue diseases can also resemble rheumatoid arthritis, so symptom location alone cannot establish the cause. 3

Clinicians look at the number and distribution of affected joints, the duration of symptoms, stiffness after rest, examination findings and changes over time. Rheumatoid arthritis commonly begins as an inflammatory arthritis that gradually involves additional joints, but presentation varies. A specialist may consider whether symptoms fit another inflammatory condition, a mechanical problem, infection or medication-related effect. This distinction matters because treatments that suppress immune activity may be inappropriate when an untreated infection is present.

Diagnosis and specialist assessment

Assessment generally begins with a medical history and physical examination. Blood testing may include rheumatoid factor, anti-cyclic citrullinated peptide antibodies, erythrocyte sedimentation rate and C-reactive protein, although positive or negative results do not independently confirm or exclude the disease. X-rays, ultrasound or other imaging may help identify inflammation or structural change. Diagnosis is based on the overall clinical picture, sometimes with serial observation when the pattern is still developing. 1 3

Rheumatologists are physicians specializing in inflammatory and autoimmune diseases affecting joints and related organs. Care may be available through hospital rheumatology departments, university medical centers and specialist outpatient practices. Examples of recognized clinical institutions appearing in medical reference material include Penn Medicine and Cleveland Clinic. 1 4 Appointment timing varies by location, referral requirements, clinician availability and symptom urgency. Primary-care records, medication details, symptom dates, affected joints and previous test results can make the first consultation more efficient.

Treatment options and how they work

Disease-modifying antirheumatic drugs are central to rheumatoid arthritis care because they target immune-driven inflammation and are intended to reduce the risk of progressive joint damage. Methotrexate and other conventional medicines may be considered first, while biologic medicines and targeted synthetic medicines act on specific immune pathways. Choice depends on disease activity, other medical conditions, pregnancy considerations, infection risk, previous treatments and monitoring results. Treatment response and tolerability require continuing professional review.

Non-drug care can include physical therapy, occupational therapy, prescribed exercise, joint protection, splints and strategies to maintain movement. Nonsteroidal anti-inflammatory medicines or corticosteroids may help control symptoms, but they do not replace disease-modifying treatment and can carry gastrointestinal, kidney, bone, blood-pressure or infection-related risks. Joint injections may be used in selected circumstances. Surgery, including joint reconstruction or replacement, may be considered when structural damage causes persistent functional loss despite other approaches.

Risks, monitoring and treatment limitations

Immune-modifying medicines can increase susceptibility to infections and may require screening, vaccination review and periodic blood tests. Methotrexate can affect the liver, blood counts and lungs in some circumstances, while biologic and targeted medicines have medicine-specific warnings. Infusions can cause administration reactions, and injections can cause local reactions. Nonsteroidal anti-inflammatory medicines may affect the stomach, kidneys or cardiovascular system. A qualified professional should review risks against the condition being treated before therapy begins.

No single medicine is suitable for every case, and treatment may need adjustment when inflammation remains active, side effects occur or another diagnosis becomes more likely. Monitoring may include blood counts, liver and kidney tests, inflammatory markers, tuberculosis or hepatitis screening, and imaging when clinically appropriate. Public and private coverage rules can influence which medicine is considered first, whether prior authorization is required and whether treatment is given at home, in a clinic or in a hospital outpatient department.

United States costs and access considerations

Published 2026 estimates place biologic drug acquisition at approximately $2,100 to $9,000 per month, with an average estimate of $4,500. Administration and infusion charges are separately estimated at roughly $650 to $4,000, while monitoring and laboratory testing may range from $120 to $1,000. These are market estimates rather than bills for a specific person, and the medicine, dose, setting, region and coverage arrangement can materially change the total. 5

Another 2026 cost guide estimates total treatment at approximately $2,500 to $6,000 per hospital-based infusion, compared with about $1,000 to $1,750 at a specialty infusion center. The same source reports hospital outpatient estimates of roughly $1,850 to $4,400 per treatment. Facility fees, medicine acquisition, administration, laboratory work and clinician charges may appear as separate components. 6 Public programs and private coverage may reduce the patient share, but deductibles, copayments, eligibility rules, authorization requirements and annual limits can still affect expenses. Appointment and treatment waiting times vary, so a clinician can clarify expected scheduling after reviewing the symptoms and referral pathway.

Sources

1. Rheumatoid arthritis: https://www.pennmedicine.org/conditions/rheumatoid-arthritis
2. Rheumatoid Arthritis - Harvard Health: https://www.health.harvard.edu/bones-and-joints/rheumatoid-arthritis-a-to-z
3. Diagnostic Criteria| Rheumatoid Arthritis | Clinical Guidance: https://www.healio.com/clinical-guidance/rheumatoid-arthritis/diagnostic-criteria-presentation-and-diagnosis
4. Rheumatoid Arthritis (RA) - Bone, Joint, and Muscle Disorders - Merck Manual Consumer Version: https://www.merckmanuals.com/home/bone-joint-and-muscle-disorders/joint-disorders/rheumatoid-arthritis-ra
5. Rheumatoid Arthritis Biologics Cost Guide – Cost Digest: https://costdigest.org/rheumatoid-arthritis-biologics-cost/
6. IV Infusion Cost: What You'll Pay for Remicade, Vyvgart & Specialty Treatments (2026): https://ameripharmainfusioncenter.com/iv-infusion-cost-remicade-vyvgart-comparison-aic/